Form 4: Synopsys Chief Revenue Officer Executes Stock Transactions Under 10b5-1 Plan

Synopsys' Chief Revenue Officer, Richard S. Mahoney, executed multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

Summary

• Richard S. Mahoney, Chief Revenue Officer of Synopsys Inc., engaged in several transactions involving the company's common stock on January 15, 2025.
• These transactions included the exercise of non-qualified stock options and the subsequent sale of shares.
• The stock options were exercised at prices of $319.20 and $354.45 per share.
• The sales of common stock occurred at weighted average prices of $505.9868, $505.9672 and $506.071 per share.
• A total of 10,322 shares were acquired through option exercises at $319.20 and then sold, and 4,173 shares were acquired through option exercises at $354.45 and then sold.
• An additional 6,343 shares were sold at a weighted average price of $506.071.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 13, 2024.

Sentiment

Score: 6

Explanation: The document reflects routine insider trading activity under a pre-arranged plan. While the sale of shares could be perceived negatively, the use of a 10b5-1 plan mitigates this concern. The sentiment is neutral to slightly positive.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a common practice for corporate insiders to avoid accusations of insider trading.
• The exercise of stock options indicates that the executive believes in the long-term value of the company.

Negatives

• The sale of shares by a high-ranking executive could be interpreted negatively by some investors, although it is part of a pre-planned strategy.

Risks

• While the transactions are part of a pre-planned trading plan, large sales by insiders can sometimes create short-term downward pressure on the stock price.
• The market may react negatively to the sale of shares by a key executive, even if it is part of a pre-arranged plan.

Industry Context

The use of 10b5-1 trading plans is a common practice among corporate executives to manage their personal finances while avoiding potential insider trading issues. This filing is a routine disclosure of such activity.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a standard practice among executives at publicly traded companies, including Synopsys' competitors in the electronic design automation (EDA) industry such as Cadence Design Systems and Mentor Graphics (now part of Siemens).
• These plans allow executives to sell shares without being accused of trading on inside information, aligning with best practices in corporate governance.
• The reported transactions are consistent with typical insider trading activity under such plans, where executives exercise options and sell shares for personal financial management.

Stakeholder Impact

• Shareholders may react to the sale of shares by a key executive, although the pre-planned nature of the transactions should mitigate any negative impact.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Synopsys, Stock Options, Insider Trading, Form 4, Rule 10b5-1, Richard S. Mahoney, Chief Revenue Officer, Stock Sale, Equity Securities